swarajyamag.com – Krishna Ella, Executive Chairman of BBIL, said: ‘We have developed Covaxin and iNCOVACC, two COVID vaccines from two different platforms, with two different delivery systems. The vectored intranasal …

Tweeted by @SwarajyaMag https://twitter.com/SwarajyaMag/status/1607683960892424195